Losses Continue for Exxon in Q3; Dividend Is Safe
Despite three consecutive quarterly losses, we're maintaining our $74 fair value estimate and narrow moat rating.
Exxon (XOM) reported its third consecutive quarterly loss, as the COVID-19 pandemic continued to weigh on commodity prices. Third-quarter adjusted earnings fell to a loss of $793 million from adjusted earnings of $2.9 billion last year, but improved from a $3 billion loss in the second quarter. We plan to incorporate the latest results into our forecast but do not expect a material change to our fair value estimate or narrow moat rating.
Exxon returned to generating free cash flow during the quarter, as $4.5 billion in operating cash flow and proceeds from asset sales exceeded $3.8 billion in investments. Free cash flow was insufficient to cover $3.7 billion of quarterly dividends, though, requiring use of cash on hand and increasing net debt even though gross debt fell slightly. Leverage remains manageable, however. The sustainability of the dividend remains the key near-term question for Exxon shareholders as continued share price decline has the yield just under 11%. Management reiterated the dividend but did without any growth this year, keeping the quarterly payout at $0.87 a share.
The dividend appears safe for now, with management stressing its commitment to providing a reliable growing dividend. It believes that the dividend is safe through 2021 with its latest capital plan (reduction in capital spending to $16 billion-$19 billion) and operating expense reductions without increasing debt, assuming a recovery in market conditions for oil and gas prices and refining and chemical margins to the low level of the past 10 years. During the third quarter, oil prices were slightly below those levels, while natural gas prices and downstream margins were well below those levels. Assuming a continued economic recovery, then, the dividend should remain safe.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
Allen Good does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.